DOI:
10.1055/s-00000014
Erfahrungsheilkunde
LinksClose Window
References
Zheng Y, Yu T, Tang Y. et al.
Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable
bowel syndrome: a systematic review and meta-analysis of randomized controlled
trials.
Plos One 2017;
12: e0172846 doi:10.1371/journal.pone.0172846
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.